AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Fusion Antibodies plc

10.89p -$2.61 (-19.33%)
LSE · 16 Sep 2026 07:00 UTC
Previous Close
10.75p
Day Range
10.5p10.89p
Year Range
9p21p
Market Cap
13.63M
AVG Volume
373.54K
Trailing/Forward PE
-7.56/-
PEG ratio
0.53
Dividend Yield
-
Next Earnings Date
2026-12-07
Primary Exchange
London Stock ExchangeUK
Revenue (GBP)
01M2M3M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Revenue (GBP) by quarter
PeriodRevenue (GBP)
25 Q2838K
24 Q4758K
24 Q21.21M
23 Q4595K
23 Q2541K
22 Q41.04M
22 Q21.86M
21 Q42.36M
21 Q22.44M
20 Q42.26M
Net Income (GBP)
-3M-2M-1M020 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
25 Q2-512K
24 Q4-955K
24 Q2-758K
23 Q4-869K
23 Q2-1.36M
22 Q4-1.48M
22 Q2-1.12M
21 Q4-616K
21 Q2-584K
20 Q4-2.43M
Operating Income (GBP)
-2M-1.5M-1M-500K020 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
25 Q2-910K
24 Q4-985K
24 Q2-794K
23 Q4-873K
23 Q2-1.42M
22 Q4-1.6M
22 Q2-1.26M
21 Q4-660K
21 Q2-695K
20 Q4-837K
EBITDA (GBP)
-1.5M-1M-500K020 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
25 Q2-476K
24 Q4-888K
24 Q2-736K
23 Q4-773K
23 Q2-1.29M
22 Q4-1.47M
22 Q2-1.01M
21 Q4-299K
21 Q2-274K
20 Q4-315K
Cash Flows (GBP)
-1.5M-1M-500K0500K20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
25 Q2-635K
24 Q4-622K
24 Q2-752K
23 Q4-421K
23 Q2-1.35M
22 Q4-751K
22 Q2-1.12M
21 Q4107K
21 Q2-698K
20 Q4-511K
EPS (GBP)
-0.1-0.08-0.05-0.03-020 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L EPS (GBP) by quarter
PeriodEPS (GBP)
25 Q2-0
24 Q4-0.01
24 Q2-0.01
23 Q4-0.02
23 Q2-0.03
22 Q4-0.06
22 Q2-0.04
21 Q4-0.02
21 Q2-0.02
20 Q4-0.09
Expenses (GBP)
-1M01M2M3MR&DSG&ACapex20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
25 Q21.16M
24 Q4942K
24 Q21.12M
23 Q4819K
23 Q21.21M
22 Q41.2M
22 Q21.98M
21 Q41.62M
21 Q21.71M
20 Q42.05M
Cash & Debt (GBP)
01M2M3MCashLong Term DebtShort Term Debt20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
25 Q2252K
24 Q4359K
24 Q2439K
23 Q41.2M
23 Q2487K
22 Q4195K
22 Q21.2M
21 Q42.05M
21 Q21.99M
20 Q42.69M
Debt ratios
-1012320 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Debt ratios by quarter
PeriodDebt ratios
25 Q2-0.15
24 Q40.09
24 Q20.1
23 Q40.25
23 Q20.11
22 Q40.04
22 Q20.46
21 Q41.79
21 Q21.98
20 Q42.55
Margins
-40%-20%0%20%40%20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Margins by quarter
PeriodMargins
25 Q222.08%
24 Q413.85%
24 Q226.93%
23 Q4-9.41%
23 Q2-38.63%
22 Q4-15.13%
22 Q219.27%
21 Q437.7%
21 Q233.92%
20 Q434.6%
Return on Capital
-150%-100%-50%0%20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Return on Capital by quarter
PeriodReturn on Capital
25 Q2-70.52%
24 Q4-142.75%
24 Q2-71.58%
23 Q4-48.47%
23 Q2-93.33%
22 Q4-131.79%
22 Q2-43.39%
21 Q4-16.72%
21 Q2-13.75%
20 Q4-51.15%
Shares Outstanding
050M100M150M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Shares Outstanding by quarter
PeriodShares Outstanding
25 Q2113.21M
24 Q496.4M
24 Q255.56M
23 Q451.03M
23 Q246.5M
22 Q426.01M
22 Q226.01M
21 Q426.01M
21 Q225.82M
20 Q425.58M
Book Value Per Share (GBP)
00.050.10.150.220 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
25 Q20.01
24 Q40.01
24 Q20.02
23 Q40.04
23 Q20.03
22 Q40.04
22 Q20.1
21 Q40.14
21 Q20.16
20 Q40.19
Total Assets (GBP)
02M4M6M20 Q421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q2
FAB.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
25 Q21.81M
24 Q41.32M
24 Q21.53M
23 Q42.42M
23 Q22.06M
22 Q42.06M
22 Q23.98M
21 Q44.92M
21 Q25.37M
20 Q45.83M
Fusion Antibodies plc
FAB.L
Stockpicker

Video analysis: FAB.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.